The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd

Promoter pledge above 50%Ownership Changes View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹399.20

prior close

₹398.60

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.4%+0.5% vs market

Healthcare Service Provider peers, median of 22sector-0.6%+1.5% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 1.5 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

+0.1

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+0.4+0.5-0.6+1.5

Next day

+2.2-0.4+2.6+0.3+2.0

+0.9-0.7+1.5+0.0+0.8

+1.2-1.0+2.2+0.5+0.7

-0.1-2.1+2.0-1.0+0.9

-6.1-4.2-1.9-2.6-3.5

-3.6-5.3+1.8-2.4-1.1

15d

+6.4-3.2+9.6-3.6+10.1

+3.8-2.3+6.1-4.3+8.1

+30.2-2.9+33.0-7.6+37.8

+9.3-7.6+16.9-15.5+24.8

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Docon Technologies, the promoter of Thyrocare, has pledged 3,23,23,232 equity shares (60.99% of Thyrocare's total share capital) in favour of Catalyst Trusteeship Limited, acting as debenture trustee. The pledge secures new secured, unlisted, redeemable non-convertible debentures issued by API Holdings (the ultimate holding company) aggregating up to Rs 1,700 crore in nominal value. The proceeds of the new debentures were used to fully redeem the existing debentures of API Holdings, which had an outstanding redemption value of Rs 1,820 crore (nominal value Rs 1,545.38 crore). Docon continues to hold 71.06% of Thyrocare post-pledge, with voting rights on the encumbered shares retained by the pledgor.

Likely market impact

While the promoter retains full ownership and voting rights, 60.99% of the company's shares are now pledged as collateral for parent-level debt, which increases risk for minority shareholders if API Holdings defaults on the new debentures. The shareholding structure and total promoter stake remain unchanged at 71.06%.